TL;DR
Anthropic is opening a physical biology lab in the San Francisco area where Claude directs robots through drug experiments, marking a direct leap from AI software into wet-lab science.
What happened
- Anthropic is building a biology lab in the San Francisco area to run physical drug experiments, not just simulations.
- Claude will guide robots through experiments with minimal human involvement, though human oversight remains required for safety.
- Two new tools underpin the effort: Claude Science, an AI workspace for researchers, and the Model Hardware Standard, a protocol for controlling lab equipment.
- Coefficient Bio was acquired in April for roughly $400 million, seeding Anthropic's life sciences capabilities.
- Vas Narasimhan, CEO of Novartis, joined Anthropic's board earlier this year, signaling deep pharma alignment.
Why it matters
- "Undruggable" diseases are the stated target: conditions with no existing treatment that have defeated conventional drug discovery.
- Claude could accelerate design of complex multi-target antibodies, a class of therapeutics that is slow and expensive to develop by hand.
- Anthropic is deliberately not running clinical trials to avoid competing with pharma partners, positioning itself as an enabler rather than a rival.
- The move puts Anthropic in direct competition with AI drug-discovery firms like Recursion, Insilico, and Isomorphic Labs, but with a frontier-model advantage.
- Owning the lab means proprietary wet-lab data flows back into model training, a feedback loop competitors without physical labs cannot replicate.
What to watch next
- Whether pharma partnerships materialize around Claude Science and the Model Hardware Standard as industry adoption signals.
- How quickly the lab produces peer-reviewed results or preclinical candidates, which would validate the robot-guided approach over simulation-only rivals.
- Whether Anthropic expands clinical-trial involvement as trust with pharma partners grows, reversing its current hands-off stance.
Originally published on Present of AI, a daily source-linked AI news timeline. Read the full timeline or browse the open dataset.